Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests that examine a tumor itself.

Meribel Pharma has established centers of excellence in drug development, lyophilization, and preservative-free multidose technologies.

Attovia Therapeutics has completed an oversubscribed $90 million Series C financing, which the company plans to use along with existing cash and investments to advance its two lead pipeline candidates ...

The partners will use Cellino's autonomous biomanufacturing tech to produce high-quality autologous iPSCs for Karis' cardiovascular therapy.